leisure time -WSS

leisure time

author：focus 2025-09-30 03:33:06 - browse：8

Person wearing a smart watch. -- first opinion coverage from STAT — Adobe

The Apple Watch has secured a new qualification from the Food and Drug Administration that could make the smartwatch an appealing tool for medical device companies hoping to illustrate the benefits of a common heart procedure.

Last week, the Apple Watch’s Atrial Fibrillation History feature became the first digital tool qualified under the Medical Device Development Tools (MDDT) program. Released in 2022, the feature estimates a user’s A-fib burden, or how much time they spend in atrial fibrillation, which is an irregular heart rhythm that can cause shortness of breath and fatigue, and is also linked to an increased risk of stroke.

The qualification means that FDA has determined in advance that sponsors can use the feature as a secondary endpoint in clinical trials without having to do additional work. Specifically, the Apple Watch is qualified for use as a secondary endpoint in clinical trials for cardiac ablation devices, which reduce the electrical signals that cause A-fib by scarring the heart with extreme heat or cold energy. Pulsed field ablation is the latest version of the technology, using a controlled electric field to scar tissue rather than the riskier thermal energy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Readout Newsletter: Cytokinetics and Novartis' starcrossed tale

WSS

5 to watch: Tech startups trying to solve health care's staffing crisis

UnitedHealth increases loan offers after Change Healthcare outage

Gene editing the human germline: What are the risks?

Physicians and social media: If you see something, say something?

Physicians and social media: If you see something, say something?

Study suggests new cause of Down syndrome: cells linked to aging

explore

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

SCOTUS questions limit to govt efforts to fight misinformation

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Plastic surgeons increase patient psychiatric screenings

Heart attack and stroke risk calculators need revising

Mayo Clinic partners with supercomputer AI firm Cerebras at JPM

Duchenne breakthrough therapy leaves behind pioneering families

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

Medicare proposal to cover medical devices draws a mixed reaction

JPM pitch from hospitals? Revenue streams outside of patient care

hotspot

Male doctors called my cancer incurable. A female doctor showed it wasn't

Neuroscience’s long legacy of racism

Medicare Advantage overpayments discussion gets experts fired up

Health AI adoption puts security, privacy startups on investors' radar

Virtual Event: March of the Biosimilars

UnitedHealth increases loan offers after Change Healthcare outage

focus

focus

hotspot

knowledge